Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 13962-13964 [2019-06846]

Download as PDF 13962 Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 8, 2019. Such persons may also file a written request for a hearing on the application on or before May 8, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. DATES: In accordance with 21 CFR 1301.34(a), this is notice that on February 4, 2019, Unither Manufacturing LLC, 331 Clay Road, Rochester, New York 14623–3226 applied to be registered as an importer of the following basic class of controlled substance: Controlled substance Drug code Methylphenidate ... 1724 Schedule II The company plans to import the listed substance solely for updated analytical testing purposes for EU customer requirements. This analysis is required to allow the company to export domestically-manufactured finished dosage forms to foreign markets. Approval of permit applications will occur only when the registrant’s activity is consistent with what is authorized under to 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or nonapproved finished dosage forms for commercial sale. Dated: March 21, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–06850 Filed 4–5–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before June 7, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on February 1, 2019, Synthcon, LLC, 770 Wooten Road, Unit 101, Colorado Springs, Colorado 80915 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Notice of application. jbell on DSK30RV082PROD with NOTICES Controlled substance Drug code Amphetamine ....................................................................................................................................................................... Methamphetamine ................................................................................................................................................................ 3-Fluoro-N-methylcathinone (3-FMC) ................................................................................................................................... Cathinone ............................................................................................................................................................................. Methcathinone ...................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4-FMC) ................................................................................................................................... Pentedrone (a-methylaminovalerophenone) ........................................................................................................................ Mephedrone (4-Methyl-N-methylcathinone) ......................................................................................................................... 4-Methyl-N-ethylcathinone (4-MEC) ..................................................................................................................................... Naphyrone ............................................................................................................................................................................ N-Ethylamphetamine ............................................................................................................................................................ N,N-Dimethylamphetamine .................................................................................................................................................. Aminorex .............................................................................................................................................................................. 4-Methylaminorex (cis isomer) ............................................................................................................................................. Gamma Hydroxybutyric Acid ................................................................................................................................................ Methaqualone ....................................................................................................................................................................... Mecloqualone ....................................................................................................................................................................... JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ........................................................................................................ ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ....................................... JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ................................................................................... JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................. VerDate Sep<11>2014 17:45 Apr 05, 2019 Jkt 247001 PO 00000 Frm 00101 Fmt 4703 Sfmt 4703 E:\FR\FM\08APN1.SGM 08APN1 1100 1105 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1585 1590 2010 2565 2572 6250 7035 7118 7173 Schedule II II I I I I I I I I I I I I I I I I I I I 13963 Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices jbell on DSK30RV082PROD with NOTICES Controlled substance Drug code JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ................................................................................................ JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ........................................................................................................... Alpha-ethyltryptamine ........................................................................................................................................................... Ibogaine ................................................................................................................................................................................ CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ...................................................................... CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................................ Lysergic acid diethylamide ................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ..................................................................................................... Tetrahydrocannabinols ......................................................................................................................................................... Mescaline ............................................................................................................................................................................. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ................................................................................................. 3,4,5-Trimethoxyamphetamine ............................................................................................................................................. 4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine ............................................................................................................................... 4-Methyl-2,5-dimethoxyamphetamine .................................................................................................................................. 2,5-Dimethoxyamphetamine ................................................................................................................................................. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ........................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine ..................................................................................................................................... 3,4-Methylenedioxyamphetamine ......................................................................................................................................... 5-Methoxy-3,4-methylenedioxyamphetamine ....................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine ....................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................ 3,4-Methylenedioxymethamphetamine ................................................................................................................................. 4-Methoxyamphetamine ....................................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine ...................................................................................................................................... Alpha-methyltryptamine ........................................................................................................................................................ Bufotenine ............................................................................................................................................................................ Diethyltryptamine .................................................................................................................................................................. Dimethyltryptamine ............................................................................................................................................................... Psilocybin ............................................................................................................................................................................. Psilocyn ................................................................................................................................................................................ 5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................. N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................ 1-(1-Phenylcyclohexyl)pyrrolidine ......................................................................................................................................... 1-Phenylcyclohexylamine ..................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]piperidine .................................................................................................................................... Phencyclidine ....................................................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ................................................................................................................................... N-Ethyl-3-piperidyl benzilate ................................................................................................................................................ N-Methyl-3-piperidyl benzilate .............................................................................................................................................. N-Benzylpiperazine .............................................................................................................................................................. 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .......................................................................................................... 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ....................................................................................................... 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ......................................................................................................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ...................................................................................................................... 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ............................................................................................................. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ........................................................................................................ 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .......................................................................................................... 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ................................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) ......................................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................................ 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .......................................................... 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) .......................................................... 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ............................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ........................................................................................................... Butylone ................................................................................................................................................................................ Pentylone .............................................................................................................................................................................. alpha-pyrrolidinopentiophenone (a-PVP) ............................................................................................................................. alpha-pyrrolidinobutiophenone (a-PBP) ............................................................................................................................... AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ......................................................................................................... 4-Anilino-N-phenethyl-4-piperidine (ANPP) .......................................................................................................................... Phenylacetone ...................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile ..................................................................................................................................... Alphaprodine ........................................................................................................................................................................ Anileridine ............................................................................................................................................................................. Cocaine ................................................................................................................................................................................ Etorphine (except HCl) ......................................................................................................................................................... Diphenoxylate ....................................................................................................................................................................... Ecgonine ............................................................................................................................................................................... Heroin ................................................................................................................................................................................... Levorphanol .......................................................................................................................................................................... Meperidine ............................................................................................................................................................................ Meperidine intermediate–A .................................................................................................................................................. Meperidine intermediate–B .................................................................................................................................................. VerDate Sep<11>2014 17:45 Apr 05, 2019 Jkt 247001 PO 00000 Frm 00102 Fmt 4703 Sfmt 4703 E:\FR\FM\08APN1.SGM 08APN1 7200 7203 7249 7260 7297 7298 7315 7348 7370 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7455 7458 7460 7470 7471 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 8333 8501 8603 9010 9020 9041 9056 9170 9180 9200 9220 9230 9232 9233 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I II II II II II II I II II I II II II II 13964 Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices Controlled substance Drug code Meperidine intermediate–C .................................................................................................................................................. Dextropropoxyphene, bulk (non-dosage forms) ................................................................................................................... Morphine ............................................................................................................................................................................... Normorphine ......................................................................................................................................................................... Acetorphine .......................................................................................................................................................................... U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .................................................................... AH-7921 (3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl]benzamide)) ...................................................................... Acetylmethadol ..................................................................................................................................................................... Allylprodine ........................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol .......................................................................................................... Alphameprodine ................................................................................................................................................................... Alphamethadol ...................................................................................................................................................................... Benzethidine ......................................................................................................................................................................... Betacetylmethadol ................................................................................................................................................................ Clonitazene ........................................................................................................................................................................... Diampromide ........................................................................................................................................................................ Diethylthiambutene ............................................................................................................................................................... Dimethylthiambutene ............................................................................................................................................................ Ketobemidone ...................................................................................................................................................................... Levo-alphacetylmethadol ...................................................................................................................................................... 1-Methyl-4-phenyl-4-propionoxypiperidine ........................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ................................................................................................................... Alfentanil ............................................................................................................................................................................... Remifentanil .......................................................................................................................................................................... Sufentanil .............................................................................................................................................................................. Carfentanil ............................................................................................................................................................................ Tilidine .................................................................................................................................................................................. Tapentadol ............................................................................................................................................................................ Fentanyl ................................................................................................................................................................................ Para-Fluorofentanyl .............................................................................................................................................................. 3-Methylfentanyl ................................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................................ Acetyl-alpha-methylfentanyl ................................................................................................................................................. Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .................................................................................... Beta-hydroxyfentanyl ............................................................................................................................................................ Beta-hydroxy-3-methylfentanyl ............................................................................................................................................. Alpha-methylthiofentanyl ...................................................................................................................................................... 3-Methylthiofentanyl ............................................................................................................................................................. Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .................................................................. Thiofentanyl .......................................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ............................................................................... Cyclopropyl Fentanyl ............................................................................................................................................................ Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ........................................................................................ The company plans to manufacture the above-listed controlled substances as analytical reference standards for distribution to its customers. No other activities for these drug codes are authorized for this registration. Dated: March 21, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–06846 Filed 4–5–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR jbell on DSK30RV082PROD with NOTICES Office of Federal Contract Compliance Programs Construction Compliance Check Letters; New Information Collection Requirements; Comment Request ACTION: Notice. VerDate Sep<11>2014 17:45 Apr 05, 2019 Jkt 247001 The Department of Labor (DOL), as part of its continuing effort to reduce paperwork and respondent burden, conducts a pre-clearance consultation program to provide the general public and federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (PRA). The program helps to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. Currently, the Office of Federal Contract Compliance Programs (OFCCP) is soliciting comments concerning its proposal to obtain approval from the Office of Management and Budget (OMB) to implement the Construction Compliance Check Letters. A copy of SUMMARY: PO 00000 Frm 00103 Fmt 4703 Sfmt 4703 9234 9273 9300 9313 9319 9547 9551 9601 9602 9603 9604 9605 9606 9607 9612 9615 9616 9619 9628 9648 9661 9663 9737 9739 9740 9743 9750 9780 9801 9812 9813 9814 9815 9821 9830 9831 9832 9833 9834 9835 9843 9845 9850 Schedule II II II I I I I I I I I I I I I I I I I II I I II II II II I II II I I I I I I I I I I I I I I the proposed information collection request can be obtained by contacting the office listed below in the FOR FURTHER INFORMATION CONTACT section of this Notice or by accessing it at www.regulations.gov. Written comments must be submitted to the office listed in the addresses section below on or before June 7, 2019. DATES: You may submit comments by any of the following methods: Electronic comments: The federal eRulemaking portal at www.regulations.gov. Follow the instructions found on that website for submitting comments. Mail, Hand Delivery, Courier: Addressed to Harvey D. Fort, Acting Director, Division of Policy and Program Development, Office of Federal Contract Compliance Programs, 200 Constitution Avenue NW, Room C–3325, Washington, DC 20210. ADDRESSES: E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Pages 13962-13964]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06846]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Synthcon, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before June 7, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
February 1, 2019, Synthcon, LLC, 770 Wooten Road, Unit 101, Colorado 
Springs, Colorado 80915 applied to be registered as a bulk manufacturer 
of the following basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Amphetamine..........................         1100  II
Methamphetamine......................         1105  II
3-Fluoro-N-methylcathinone (3-FMC)...         1233  I
Cathinone............................         1235  I
Methcathinone........................         1237  I
4-Fluoro-N-methylcathinone (4-FMC)...         1238  I
Pentedrone ([alpha]-                          1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                       1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)....         1249  I
Naphyrone............................         1258  I
N-Ethylamphetamine...................         1475  I
N,N-Dimethylamphetamine..............         1480  I
Aminorex.............................         1585  I
4-Methylaminorex (cis isomer)........         1590  I
Gamma Hydroxybutyric Acid............         2010  I
Methaqualone.........................         2565  I
Mecloqualone.........................         2572  I
JWH-250 (1-Pentyl-3-(2-                       6250  I
 methoxyphenylacetyl) indole).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-        7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-
 3-carboxamide).
JWH-018 (also known as AM678) (1-             7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-073 (1-Butyl-3-(1-                        7173  I
 naphthoyl)indole).

[[Page 13963]]

 
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-        7200  I
 (1-naphthoyl)indole).
JWH-203 (1-Pentyl-3-(2-                       7203  I
 chlorophenylacetyl) indole).
Alpha-ethyltryptamine................         7249  I
Ibogaine.............................         7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-          7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-               7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide...........         7315  I
2,5-Dimethoxy-4-(n)-                          7348  I
 propylthiophenethylamine (2C-T-7).
Tetrahydrocannabinols................         7370  I
Mescaline............................         7381  I
2-(4-Ethylthio-2,5-dimethoxyphenyl)           7385  I
 ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine..........         7390  I
4-Bromo-2,5-dimethoxyamphetamine.....         7391  I
4-Bromo-2,5-dimethoxyphenethylamine..         7392  I
4-Methyl-2,5-dimethoxyamphetamine....         7395  I
2,5-Dimethoxyamphetamine.............         7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-              7398  I
 naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine.....         7399  I
3,4-Methylenedioxyamphetamine........         7400  I
5-Methoxy-3,4-                                7401  I
 methylenedioxyamphetamine.
N-Hydroxy-3,4-                                7402  I
 methylenedioxyamphetamine.
3,4-Methylenedioxy-N-ethylamphetamine         7404  I
3,4-Methylenedioxymethamphetamine....         7405  I
4-Methoxyamphetamine.................         7411  I
5-Methoxy-N-N-dimethyltryptamine.....         7431  I
Alpha-methyltryptamine...............         7432  I
Bufotenine...........................         7433  I
Diethyltryptamine....................         7434  I
Dimethyltryptamine...................         7435  I
Psilocybin...........................         7437  I
Psilocyn.............................         7438  I
5-Methoxy-N,N-diisopropyltryptamine..         7439  I
N-Ethyl-1-phenylcyclohexylamine......         7455  I
1-(1-Phenylcyclohexyl)pyrrolidine....         7458  I
1-Phenylcyclohexylamine..............         7460  II
1-[1-(2-Thienyl)cyclohexyl]piperidine         7470  I
Phencyclidine........................         7471  II
1-[1-(2-                                      7473  I
 Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate........         7482  I
N-Methyl-3-piperidyl benzilate.......         7484  I
N-Benzylpiperazine...................         7493  I
4-Methyl-                                     7498  I
 alphapyrrolidinopropiophenone (4-
 MePPP).
2-(2,5-Dimethoxy-4-methylphenyl)              7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl)               7509  I
 ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine            7517  I
 (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl)                7518  I
 ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl)              7519  I
 ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl)              7521  I
 ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl)          7524  I
 ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-                      7532  I
 dimethoxyphenyl) ethanamine (2C-T-4
 ).
MDPV (3,4-Methylenedioxypyrovalerone)         7535  I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-         7536  I
 methoxybenzyl) ethanamine (25B-
 NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-        7537  I
 methoxybenzyl) ethanamine (25C-
 NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-          7538  I
 methoxybenzyl) ethanamine (25I-
 NBOMe).
Methylone (3,4-Methylenedioxy-N-              7540  I
 methylcathinone).
Butylone.............................         7541  I
Pentylone............................         7542  I
alpha-pyrrolidinopentiophenone                7545  I
 ([alpha]-PVP).
alpha-pyrrolidinobutiophenone                 7546  I
 ([alpha]-PBP).
AM-694 (1-(5-Fluoropentyl)-3-(2-              7694  I
 iodobenzoyl) indole).
4-Anilino-N-phenethyl-4-piperidine            8333  II
 (ANPP).
Phenylacetone........................         8501  II
1-Piperidinocyclohexanecarbonitrile..         8603  II
Alphaprodine.........................         9010  II
Anileridine..........................         9020  II
Cocaine..............................         9041  II
Etorphine (except HCl)...............         9056  I
Diphenoxylate........................         9170  II
Ecgonine.............................         9180  II
Heroin...............................         9200  I
Levorphanol..........................         9220  II
Meperidine...........................         9230  II
Meperidine intermediate-A............         9232  II
Meperidine intermediate-B............         9233  II

[[Page 13964]]

 
Meperidine intermediate-C............         9234  II
Dextropropoxyphene, bulk (non-dosage          9273  II
 forms).
Morphine.............................         9300  II
Normorphine..........................         9313  I
Acetorphine..........................         9319  I
U-47700 (3,4-dichloro-N-[2-                   9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                  9551  I
 dimethylamino)
 cyclohexylmethyl]benzamide)).
Acetylmethadol.......................         9601  I
Allylprodine.........................         9602  I
Alphacetylmethadol except levo-               9603  I
 alphacetylmethadol.
Alphameprodine.......................         9604  I
Alphamethadol........................         9605  I
Benzethidine.........................         9606  I
Betacetylmethadol....................         9607  I
Clonitazene..........................         9612  I
Diampromide..........................         9615  I
Diethylthiambutene...................         9616  I
Dimethylthiambutene..................         9619  I
Ketobemidone.........................         9628  I
Levo-alphacetylmethadol..............         9648  II
1-Methyl-4-phenyl-4-                          9661  I
 propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4-                 9663  I
 acetoxypiperidine.
Alfentanil...........................         9737  II
Remifentanil.........................         9739  II
Sufentanil...........................         9740  II
Carfentanil..........................         9743  II
Tilidine.............................         9750  I
Tapentadol...........................         9780  II
Fentanyl.............................         9801  II
Para-Fluorofentanyl..................         9812  I
3-Methylfentanyl.....................         9813  I
Alpha-methylfentanyl.................         9814  I
Acetyl-alpha-methylfentanyl..........         9815  I
Acetyl Fentanyl (N-(1-                        9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Beta-hydroxyfentanyl.................         9830  I
Beta-hydroxy-3-methylfentanyl........         9831  I
Alpha-methylthiofentanyl.............         9832  I
3-Methylthiofentanyl.................         9833  I
Furanyl fentanyl (N-(1-                       9834  I
 phenethylpiperidin-4-yl)-N-
 phenylfuran-2-carboxamide).
Thiofentanyl.........................         9835  I
N-(1-phenethylpiperidin-4-yl)-N-              9843  I
 phenyltetrahydrofuran-2-carboxamide.
Cyclopropyl Fentanyl.................         9845  I
Fentanyl related-compounds as defined         9850  I
 in 21 CFR 1308.11&h).
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances as analytical reference standards for distribution to its 
customers. No other activities for these drug codes are authorized for 
this registration.

    Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06846 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P